FC
Fayerweather Charles Portfolio holdings
AUM
$57.2M
This Quarter Return
+4.38%
1 Year Return
+11.87%
3 Year Return
+47.45%
5 Year Return
+76.34%
10 Year Return
–
AUM
$29.5M
AUM Growth
+$29.5M
(+1.9%)
Cap. Flow
-$405K
Cap. Flow
% of AUM
-1.37%
Top 10 Holdings %
Top 10 Hldgs %
44.65%
Holding
46
New
2
Increased
9
Reduced
23
Closed
2
Top Buys
| 1 |
Perrigo
PRGO
|
$259K |
| 2 |
MON
Monsanto Co
MON
|
$203K |
| 3 |
Abbott
ABT
|
$54.7K |
| 4 |
Helmerich & Payne
HP
|
$43.8K |
| 5 |
Johnson & Johnson
JNJ
|
$43.4K |
Top Sells
| 1 |
GSK
GSK
|
$301K |
| 2 |
Exxon Mobil
XOM
|
$237K |
| 3 |
Novo Nordisk
NVO
|
$202K |
| 4 |
Union Pacific
UNP
|
$95.3K |
| 5 |
Microsoft
MSFT
|
$88.3K |
Sector Composition
| 1 | Industrials | 25.18% |
| 2 | Technology | 24.01% |
| 3 | Healthcare | 22.04% |
| 4 | Consumer Staples | 9.27% |
| 5 | Energy | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABB
26
DELISTED
ABB Ltd.
ABB
| $413K | 1.4% |
19,520
| – | – |
|
27
Home Depot
HD
$404B
| $383K | 1.3% |
3,650
| – | – |
|
|
28
Helmerich & Payne
HP
$2.11B
| $361K | 1.23% |
5,360
+650
| +14% | +$43.8K |
|
29
Rockwell Automation
ROK
$37.9B
| $360K | 1.22% |
3,245
| – | – |
|
30
Cisco
CSCO
$269B
| $358K | 1.22% |
12,850
-60
| -0.5% | -$1.67K |
|
31
Fiserv
FI
$73.7B
| $316K | 1.07% |
4,445
+20
| +0.5% | +$1.42K |
|
32
IBM
IBM
$225B
| $316K | 1.07% |
1,968
| – | – |
|
33
Oracle
ORCL
$629B
| $314K | 1.07% |
7,000
| – | – |
|
34
Mastercard
MA
$535B
| $310K | 1.05% |
3,605
-15
| -0.4% | -$1.29K |
|
35
Bristol-Myers Squibb
BMY
$96.4B
| $307K | 1.04% |
5,200
| – | – |
|
36
Cognizant
CTSH
$35.1B
| $295K | 1% |
5,600
| – | – |
|
37
Target
TGT
$42B
| $276K | 0.94% |
3,630
| – | – |
|
|
DD
38
DELISTED
Du Pont De Nemours E I
DD
| $266K | 0.9% |
3,600
| – | – |
|
|
39
Perrigo
PRGO
$3.21B
| $259K | 0.88% |
+1,555
| New | +$259K |
|
|
APC
40
DELISTED
Anadarko Petroleum
APC
| $248K | 0.84% |
3,001
-15
| -0.5% | -$1.24K |
|
41
Corning
GLW
$58.4B
| $223K | 0.76% |
9,760
-420
| -4% | -$9.6K |
|
|
MON
42
DELISTED
Monsanto Co
MON
| $203K | 0.69% |
+1,700
| New | +$203K |
|
|
43
GSK
GSK
$78.4B
| – | – |
-6,555
| Closed | -$301K |
|
|
44
Novo Nordisk
NVO
$250B
| – | – |
-4,250
| Closed | -$202K |
|